Direktorat Registrasi ObatValid

REMSIMA

BPOM Number: DKI1954100144A1
Approved: 22 April 2024
Expiry: 17 November 2024
Form: SERBUK INJEKSI; 100 MG

About This Registration

REMSIMA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1954100144A1. Its current registration status is Valid, with the licence valid until 17 November 2024. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in November 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 VIAL @ 100 MG
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

SANBE FARMA
Kota Bandung, Jawa Barat, Indonesia
NPWP: 011049160092000
owner
View profile →

Manufacturing Sites

SANBE FARMA - INDONESIA
KAB. BANDUNG BARAT
primary
View profile →

Ingredients (1)

INFLIXIMAB

Market Intelligence

Owner Portfolio: SANBE FARMA holds 554 BPOM registrations
Manufacturer Scale: SANBE FARMA - INDONESIA produces 490 registered products
Registration Age: Registered for 6 years, 10 months
Expiry Status: Expired 678 days ago